Tue.Feb 11, 2025

article thumbnail

Bio-Thera signs US deal with Intas for golimumab biosimilar

Pharmaceutical Technology

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in the US.

59
article thumbnail

Judge orders block on Trump's NIH funding cuts

pharmaphorum

A US judge has imposed a temporary injunction in 22 US states on the Trump administration's sweeping cuts to NIH funding of medical research

40
article thumbnail

Obesity market to reach $173.5 billion by 2031

Pharmaceutical Technology

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease space.

59